NEW YORK, May 24 (GenomeWeb News) - An analyst at Pacific Growth Equities upgraded Illumina stock yesterday to "buy" from "neutral" after the company on Firday said it will sell 3.5 million shares of its common stock.


As GenomeWeb News reported last week, Illumina expects to pocket around $83.6 million from the sale.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.